?

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Found 5032 publications
LifeScan, Inc. Market Share Analysis US$ 1,000.00

... , analysis and strategic insight into the medical equipment business of LifeScan, Inc.. The report provides key information relating to LifeScan, Inc. medical equipment revenue, market share by sector and country, financial and SWOT analysis of the ...

Nov, 2009 28 pages
Johnson and Johnson Vision Care, Inc Market Share Analysis US$ 1,000.00

... insight into the medical equipment business of Johnson & Johnson Vision Care, Inc.. The report provides key information relating to Johnson & Johnson Vision Care, Inc. medical equipment revenue, market ...

Nov, 2009 26 pages
Ethicon, Inc. Market Share Analysis US$ 1,000.00

... , analysis and strategic insight into the medical equipment business of Ethicon, Inc.. The report provides key information relating to Ethicon, Inc. medical equipment revenue, market share by sector and country, financial and SWOT analysis of the ...

Nov, 2009 115 pages
Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts US$ 2,995.00

... Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals ...

Apr, 2014 1092 pages
Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015 US$ 2,995.00

... development deals by value since 2010 Most active co-development dealmakers since 2010 The leading co-development partnering resources In Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015 available deals ...

Apr, 2015 1005 pages
Trigeminal Neuralgia - Pipeline Review, H1 2015 US$ 2,000.00

Trigeminal Neuralgia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Trigeminal Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia ...

Feb, 2015 48 pages
Top 50 Big Pharma Partnering and M&A Deal Trends US$ 3,495.00

... big pharma companies. Top 50 Big Pharma Partnering and M&A Deal Trends provides the user with the following key benefits: Detailed partnering ...

Apr, 2015 798 pages
Salix Pharmaceuticals Partnering 2009-2014 US$ 995.00

... Agreements with Salix Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds ... 2 lists the top 50 leading big biotech companies based on 2013 pharmaceutical revenues and their respective partnering activity. Chapter 3 provides an overview ...

Nov, 2014 100 pages
Regenerative Medicine Partnering Terms and Agreements US$ 2,995.00

... royalty terms. Chapter 3 provides a review of the leading regenerative medicine deals since 2009. Deals are listed by headline value, signed by big pharma ... detailed review of all regenerative medicine partnering deals including cell therapy, organ regeneration, stem cells and tissue regeneration signed and ...

Oct, 2014 1116 pages
Jazz Pharmaceuticals Partnering 2009-2014 US$ 995.00

... Agreements with Jazz Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds ... 2 lists the top 50 leading big biotech companies based on 2013 pharmaceutical revenues and their respective partnering activity. Chapter 3 provides an overview ...

Nov, 2014 100 pages
Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics US$ 1,995.00

... will have a significant impact on each party’s ability to derive value from the deal. Report scope Global Joint Venture Partnerships in Pharma, ... dealmakers since 2009 The leading joint venture partnering resources In Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics, the available ...

Oct, 2014 652 pages
Treventis Corporation - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Treventis Corporation’s pipeline products Reasons to buy Evaluate Treventis Corporation ...

Aug, 2014 22 pages
Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014’, provides an overview of the Sol-Gel Technologies Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sol-Gel Technologies Ltd ...

Aug, 2014 18 pages
NeoPharm Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the NeoPharm Co., Ltd.’s pipeline products Reasons to buy Evaluate NeoPharm Co., Ltd ...

Aug, 2014 31 pages
Molecular Templates Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Molecular Templates Inc.’s pipeline products Reasons to buy Evaluate Molecular Templates Inc ...

Aug, 2014 29 pages
Intezyne, Inc - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Intezyne, Inc’s pipeline products Reasons to buy Evaluate Intezyne, Inc ...

Aug, 2014 27 pages
EyeCyte, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the EyeCyte, Inc.’s pipeline products Reasons to buy Evaluate EyeCyte, Inc ...

Aug, 2014 20 pages
Da Volterra - Product Pipeline Review - 2014 US$ 1,500.00

... Volterra - Product Pipeline Review - 2014’, provides an overview of the Da Volterra’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Da Volterra ...

Aug, 2014 21 pages
CYATHUS EXQUIRERE PharmaforschungsGmbH - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the CYATHUS EXQUIRERE PharmaforschungsGmbH’s pipeline products Reasons to buy Evaluate CYATHUS EXQUIRERE PharmaforschungsGmbH ...

Aug, 2014 17 pages
AllTranz, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AllTranz, Inc.’s pipeline products Reasons to buy Evaluate AllTranz, Inc ...

Aug, 2014 21 pages
vasopharm GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the vasopharm GmbH’s pipeline products Reasons to buy Evaluate vasopharm GmbH ...

Aug, 2014 22 pages
Tacere Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Tacere Therapeutics, Inc.’s pipeline products Reasons to buy Evaluate Tacere Therapeutics, Inc ...

Jul, 2014 27 pages
Phenomenome Discoveries, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Phenomenome Discoveries, Inc.’s pipeline products Reasons to buy Evaluate Phenomenome Discoveries, Inc ...

Jul, 2014 20 pages
Northern Antibiotics Oy - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Northern Antibiotics Oy’s pipeline products Reasons to buy Evaluate Northern Antibiotics ...

Aug, 2014 21 pages
Koronis Pharma, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Koronis Pharma, Inc.’s pipeline products Reasons to buy Evaluate Koronis Pharma, Inc ...

Aug, 2014 24 pages
Haemostatix Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Haemostatix Ltd’s pipeline products Reasons to buy Evaluate Haemostatix Ltd ...

Jul, 2014 20 pages
Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Constellation Pharmaceuticals, Inc.’s pipeline products Reasons to buy Evaluate Constellation Pharmaceuticals, Inc ...

Aug, 2014 20 pages
Cognosci, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Cognosci, Inc.’s pipeline products Reasons to buy Evaluate Cognosci, Inc ...

Aug, 2014 29 pages
Adiga Life Sciences Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... Adiga Life Sciences Inc. - Product Pipeline Review - 2014’, provides an overview of the Adiga Life Sciences Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Adiga Life Sciences Inc ...

Aug, 2014 16 pages
Umecrine Mood AB - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Umecrine Mood AB’s pipeline products Reasons to buy Evaluate Umecrine Mood ...

Jul, 2014 21 pages
Targazyme, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Targazyme, Inc.’s pipeline products Reasons to buy Evaluate Targazyme, Inc ...

Jul, 2014 20 pages
Laboratorios Sophia S.A. de C.V. - Product Pipeline Review - 2014 US$ 1,500.00

... portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Laboratorios Sophia S.A. de C.V.’s pipeline products Reasons to buy Evaluate Laboratorios Sophia ...

Jul, 2014 21 pages
Immune Targeting Systems (ITS) Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... Immune Targeting Systems (ITS) Ltd.’s pipeline products Reasons to buy Evaluate Immune Targeting Systems (ITS) Ltd.’s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Immune Targeting Systems (ITS) Ltd. in its ...

Jul, 2014 20 pages
Echo Pharmaceuticals B.V. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Echo Pharmaceuticals B.V.’s pipeline products Reasons to buy Evaluate Echo Pharmaceuticals ...

Jul, 2014 23 pages
Sun Pharmaceutical 2009-2014 US$ 995.00

... Partnering Agreements with Sun pharmaceutical 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds ... of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the ...

Nov, 2014 100 pages
Zhejiang Hisun Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Zhejiang Hisun Pharmaceutical Co., Ltd.’s pipeline products Reasons to buy Evaluate Zhejiang Hisun Pharmaceutical Co., Ltd ...

Jul, 2014 29 pages
RuiYi Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the RuiYi Inc.’s pipeline products Reasons to buy Evaluate RuiYi Inc ...

Jul, 2014 26 pages
Provecs Medical GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Provecs Medical GmbH’s pipeline products Reasons to buy Evaluate Provecs Medical GmbH ...

Jul, 2014 19 pages
ProCertus BioPharm Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the ProCertus BioPharm Inc.’s pipeline products Reasons to buy Evaluate ProCertus BioPharm Inc ...

Jul, 2014 21 pages
Nerviano Medical Sciences - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Nerviano Medical Sciences ’s pipeline products Reasons to buy Evaluate Nerviano Medical Sciences ...

Jul, 2014 52 pages
Navya Biologicals Pvt Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... Navya Biologicals Pvt Ltd - Product Pipeline Review - 2014’, provides an overview of the Navya Biologicals Pvt Ltd’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Navya Biologicals Pvt Ltd ...

Jul, 2014 25 pages
Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Janssen Pharmaceuticals, Inc.’s pipeline products Reasons to buy Evaluate Janssen Pharmaceuticals, Inc ...

Jul, 2014 28 pages
CoMentis, Inc. - Product Pipeline Review - 2015 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the CoMentis, Inc.’s pipeline products Reasons to buy Evaluate CoMentis, Inc ...

Feb, 2015 22 pages
CerRx, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the CerRx, Inc.’s pipeline products Reasons to buy Evaluate CerRx, Inc ...

Jul, 2014 22 pages
BioCrea GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the biocrea GmbH’s pipeline products Reasons to buy Evaluate biocrea GmbH ...

Jul, 2014 26 pages
3-V Biosciences, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the 3-V Biosciences, Inc.’s pipeline products Reasons to buy Evaluate 3-V Biosciences, Inc ...

Jun, 2014 23 pages
SignPath Pharma Inc - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the SignPath Pharma Inc’s pipeline products Reasons to buy Evaluate SignPath Pharma Inc ...

Jun, 2014 22 pages
Pharmicell Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Pharmicell Co., Ltd.’s pipeline products Reasons to buy Evaluate Pharmicell Co., Ltd ...

Jul, 2014 32 pages
NuCana BioMed Limited - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the NuCana BioMed Limited’s pipeline products Reasons to buy Evaluate NuCana BioMed Limited ...

Jul, 2014 34 pages
Microbio Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Microbio Co., Ltd.’s pipeline products Reasons to buy Evaluate Microbio Co., Ltd ...

Jul, 2014 28 pages
1 2 3 4 5 >
Skip to top